Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Schwab US Dividend Equity ETF (SCHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Schwab US Dividend Equity ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B), while Schwab US Dividend Equity ETF trades at $34.01 (market cap $111.61B). The key difference: Schwab US Dividend Equity ETF is far larger — about 3.6× GE HealthCare Technologies Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Schwab US Dividend Equity ETF pays none. Which is the better fit depends on your goals.
| GEHC | SCHD | |
|---|---|---|
Market Cap | $30.93B | $111.61B |
Volume | 5,033,451 | 25,598,052 |
Sector | Health | Broad Market / Factor |
52-Week High | $88.16 | $35.21 |
52-Week Low | $59.48 | $26.44 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 64 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
SCHD trades at $33.37, up 0.33% on the day, with a bullish technical signal driven by moving averages. The ETF's dividend-focused strategy is highlighted in recent news, with articles noting its outperformance against the S&P 500 in 2026 and its appeal for income investors. Key support and resistance cluster around $33, while RSI levels show mixed momentum signals.
Outlook remains positive for dividend growth and defensive positioning, but risks include interest rate sensitivity and potential missed gains from strict stock selection rules. Investors benefit from lower fees and rising payouts, though macroeconomic shifts could pressure yields.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Schwab US Dividend Equity ETF
SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →
